Medalla, Basilisa S.
HRN: 26-10-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2024
CEFUROXIME 1.5GM (VIAL)
10/20/2024
10/27/2024
IV
1.5gm
Q8H
Multiple Soft Tissue Injury Secondary MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes